Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...

Fortrea (NASDAQ:FTRE – Get Free Report) had its target price decreased by analysts at The Goldman Sachs Group from $22.00 to ...

Fortrea (NASDAQ:FTRE – Get Free Report) had its price objective lowered by investment analysts at Barclays from $25.00 to $12 ...

Bearish flow noted in Wolfspeed (WOLF) with 46,483 puts trading, or 6x expected. Most active are Mar-25 4 puts and Apr-25 6 calls, with total ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...